UROVIST SODIUM 300 Drug Patent Profile
When do Urovist Sodium 300 patents expire, and when can generic versions of Urovist Sodium 300 launch?
Urovist Sodium 300 is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in UROVIST SODIUM 300 is diatrizoate sodium. There is one drug master file entry for this compound. Additional details are available on the diatrizoate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for UROVIST SODIUM 300?
- What are the global sales for UROVIST SODIUM 300?
- What is Average Wholesale Price for UROVIST SODIUM 300?
Summary for UROVIST SODIUM 300
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Patent Applications: | 5,189 |
| DailyMed Link: | UROVIST SODIUM 300 at DailyMed |
US Patents and Regulatory Information for UROVIST SODIUM 300
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | UROVIST SODIUM 300 | diatrizoate sodium | INJECTABLE;INJECTION | 087725-001 | Sep 23, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
